1. Acceptance of Terms MEDQOR, LLC (collectively, ” we “) provide our Internet sites and the content, products and services offered on or through those sites (collectively, the “Services“), to you subject to the following Terms...
Read MorePrivacy Policy Medqor (referred to in this Privacy Statement as “we” or “Medqor”) recognize the importance of protecting the privacy of all information provided by users of our web sites, subscribers to...
Read MoreA new study presented at the Orthopaedic Research Society (ORS) 2012 Annual Meeting highlights an orthopaedic device that may improve efficiency and cost-effectiveness of post-surgical diagnosis and follow-ups.
Read MoreResearchers at the Beth Israel Deaconess Medical Center report that air pollution, even at the moderate level considered generally safe by federal regulations, may increase the risk of stroke by 34%.
Read MoreOPTP announces its new and expanded Volume 27 Catalog, designed for health care and fitness professionals.
Read MoreIn a recent news release, the Kessler Foundation recently announced that it has awarded a Signature Employment Grant to NTI, a non-profit organization designed to place Americans with disabilities nationwide in work-at-home jobs.
Read MoreA recent article appearing in the Journal of Neurotrauma spotlights a new therapeutic strategy that may improve outcomes in spinal cord injury (SCI) patients.
Read MoreThe Centers for Medicare & Medicaid Services (CMS) is reportedly considering the restriction or elimination of coverage for transcutaneous electrical nerve stimulation (TENS), used to treat chronic low back pain.
Read MoreResearchers recently presented new data at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), which suggests that excessive high impact sport activities may impair the long-term success of hip resurfacing arthroplasty.
Read MoreAccording to a recent news release, the Myelin Repair Foundation (MRF) and ENDECE Neural LLC have collaborated in order to expedite the advancement of potential myelin regeneration drugs for multiple sclerosis (MS) patients via pre-clinical studies and into Phase I clinical studies.
Read More